Literature DB >> 20011131

Depression in Age-Related Macular Degeneration.

Robin Casten, Barry Rovner.   

Abstract

Age-related macular degeneration (AMD) is a major cause of disability in the elderly, substantially degrades the quality of their lives, and is a risk factor for depression. Rates of depression in AMD are substantially greater than those found in the general population of older people, and are on par with those of other chronic and disabling diseases. This article discusses the effect of depression on vision-related disability in patients with AMD, suggests methods for screening for depression, and summarizes interventions for preventing depression in this high-risk group.

Entities:  

Year:  2008        PMID: 20011131      PMCID: PMC2792986     

Source DB:  PubMed          Journal:  J Vis Impair Blind        ISSN: 0145-482X


  26 in total

1.  Self-management of age-related macular degeneration and quality of life: a randomized controlled trial.

Authors:  Barbara L Brody; Anne-Catherine Roch-Levecq; Anthony C Gamst; Kellie Maclean; Robert M Kaplan; Stuart I Brown
Journal:  Arch Ophthalmol       Date:  2002-11

2.  Preventing depression in age-related macular degeneration.

Authors:  Barry W Rovner; Robin J Casten; Mark T Hegel; Benjamin E Leiby; William S Tasman
Journal:  Arch Gen Psychiatry       Date:  2007-08

3.  Depression and disability associated with impaired vision: the MoVies Project.

Authors:  B W Rovner; M Ganguli
Journal:  J Am Geriatr Soc       Date:  1998-05       Impact factor: 5.562

4.  Dissatisfaction with performance of valued activities predicts depression in age-related macular degeneration.

Authors:  Barry W Rovner; Robin J Casten; Mark T Hegel; Walter W Hauck; William S Tasman
Journal:  Int J Geriatr Psychiatry       Date:  2007-08       Impact factor: 3.485

5.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

6.  Anxiety and depression prevalence rates in age-related macular degeneration.

Authors:  Albert Augustin; José-Alain Sahel; Francesco Bandello; Roland Dardennes; Frédérique Maurel; Cristina Negrini; Klaus Hieke; Gilles Berdeaux
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-04       Impact factor: 4.799

7.  The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study.

Authors:  R Klein; B E Klein; S C Jensen; S M Meuer
Journal:  Ophthalmology       Date:  1997-01       Impact factor: 12.079

8.  Self-management of age-related macular degeneration at the 6-month follow-up: a randomized controlled trial.

Authors:  Barbara L Brody; Anne-Catherine Roch-Levecq; Ronald G Thomas; Robert M Kaplan; Stuart I Brown
Journal:  Arch Ophthalmol       Date:  2005-01

Review 9.  Subthreshold depression as a risk indicator for major depressive disorder: a systematic review of prospective studies.

Authors:  P Cuijpers; F Smit
Journal:  Acta Psychiatr Scand       Date:  2004-05       Impact factor: 6.392

10.  Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study.

Authors:  Gisèle Soubrane; Alan Cruess; Andrew Lotery; Daniel Pauleikhoff; Jordi Monès; Xiao Xu; Gergana Zlateva; Ronald Buggage; John Conlon; Thomas F Goss
Journal:  Arch Ophthalmol       Date:  2007-09
View more
  13 in total

1.  Why visually impaired older adults often do not receive mental health services: the patient's perspective.

Authors:  Hilde P A van der Aa; Mirke Hoeben; Linda Rainey; Ger H M B van Rens; Hilde L Vreeken; Ruth M A van Nispen
Journal:  Qual Life Res       Date:  2014-11-15       Impact factor: 4.147

2.  Age-related macular degeneration and mortality in older women: the study of osteoporotic fractures.

Authors:  Kathryn L Pedula; Anne L Coleman; Fei Yu; Jane A Cauley; Kristine E Ensrud; Marc C Hochberg; Howard A Fink; Teresa A Hillier
Journal:  J Am Geriatr Soc       Date:  2015-05-04       Impact factor: 5.562

3.  Poor vision, functioning, and depressive symptoms: a test of the activity restriction model.

Authors:  Jamila Bookwala; Brendan Lawson
Journal:  Gerontologist       Date:  2011-07-06

4.  Measurement of Perceived Stress in Age-Related Macular Degeneration.

Authors:  Bradley E Dougherty; San-San L Cooley; Frederick H Davidorf
Journal:  Optom Vis Sci       Date:  2017-03       Impact factor: 1.973

5.  Understanding the patient's lived experience of neovascular age-related macular degeneration: a qualitative study.

Authors:  C McCloud; S Lake
Journal:  Eye (Lond)       Date:  2015-09-18       Impact factor: 3.775

Review 6.  Ranibizumab: a review of its use in the treatment of neovascular age-related macular degeneration.

Authors:  James E Frampton
Journal:  Drugs Aging       Date:  2013-05       Impact factor: 3.923

Review 7.  Depression in the elderly with visual impairment and its association with quality of life.

Authors:  Judith Renaud; Emmanuelle Bédard
Journal:  Clin Interv Aging       Date:  2013-07-19       Impact factor: 4.458

8.  Watchful waiting for subthreshold depression and anxiety in visually impaired older adults.

Authors:  Hilde P A van der Aa; Esther Krijnen-de Bruin; Ger H M B van Rens; Jos W R Twisk; Ruth M A van Nispen
Journal:  Qual Life Res       Date:  2015-06-18       Impact factor: 4.147

9.  The psychological challenge of late-life vision impairment: concepts, findings, and practical implications.

Authors:  Hans-Werner Wahl
Journal:  J Ophthalmol       Date:  2013-04-17       Impact factor: 1.909

10.  Co-morbidity of depression and anxiety in common age-related eye diseases: a population-based study of 662 adults.

Authors:  Ranmalee Eramudugolla; Joanne Wood; Kaarin J Anstey
Journal:  Front Aging Neurosci       Date:  2013-10-02       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.